Latest CYCN reports update at 2024-05-07: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Cyclerion Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Cyclerion Therapeutics logo
Cyclerion Therapeutics CYCN
$ 3.0 4.6%
mail-toReport an Error

Cyclerion Therapeutics EV/EBITDA Ratio 2011-2024 | CYCN

Annual EV/EBITDA Ratio Cyclerion Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
0.271 -0.637 0.0147 - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.271 -0.637 -0.117